NDC 36987-2081

Rhizopus oryzae

Rhizopus Oryzae

Rhizopus oryzae is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Rhizopus Arrhizus Var. Arrhizus.

Product ID36987-2081_d12744f1-9486-4d31-b57b-38009e772ed7
NDC36987-2081
Product TypeHuman Prescription Drug
Proprietary NameRhizopus oryzae
Generic NameRhizopus Oryzae
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameRHIZOPUS ARRHIZUS VAR. ARRHIZUS
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-2081-3

30 mL in 1 VIAL, MULTI-DOSE (36987-2081-3)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-2081-3 [36987208103]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2081-1 [36987208101]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2081-4 [36987208104]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2081-2 [36987208102]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
RHIZOPUS ARRHIZUS VAR. ARRHIZUS.1 g/mL

OpenFDA Data

SPL SET ID:b2648ee2-1d05-4f7d-b6f5-a6cad19e2bfd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 854133
  • 892677
  • 852469
  • 1006326
  • 852105
  • 968480
  • 852401
  • 1012148
  • 1011991
  • 852375
  • 968143
  • 1010906
  • 967949
  • 967869
  • 901848
  • 889542
  • 852763
  • 968210
  • 1006290
  • 967534
  • 905075
  • 1012033
  • 852192
  • 968448
  • 966685
  • 889587
  • 889620
  • 995697
  • 1012102
  • 852060
  • 967053
  • 967032
  • 1012043
  • Pharm Class PE
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Increased Histamine Release [PE]
  • PHarm Class EPC
  • Non-Standardized Fungal Allergenic Extract [EPC]
  • NUI Code
  • N0000185001
  • N0000175629
  • N0000171131
  • N0000185372
  • N0000169106
  • N0000184306
  • Pharmacological Class

    • Non-Standardized Fungal Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Fungal Proteins [Chemical/Ingredient]
    • Allergens [Chemical/Ingredient]

    NDC Crossover Matching brand name "Rhizopus oryzae" or generic name "Rhizopus Oryzae"

    NDCBrand NameGeneric Name
    22840-2619Rhizopus oryzaeRhizopus oryzae
    22840-2620Rhizopus oryzaeRhizopus oryzae
    22840-2621Rhizopus oryzaeRhizopus oryzae
    22840-5633Rhizopus oryzaeRhizopus oryzae
    36987-2073Rhizopus oryzaeRhizopus oryzae
    36987-2074Rhizopus oryzaeRhizopus oryzae
    36987-2075Rhizopus oryzaeRhizopus oryzae
    36987-2076Rhizopus oryzaeRhizopus oryzae
    36987-2077Rhizopus oryzaeRhizopus oryzae
    36987-2078Rhizopus oryzaeRhizopus oryzae
    36987-2079Rhizopus oryzaeRhizopus oryzae
    36987-2080Rhizopus oryzaeRhizopus oryzae
    36987-2081Rhizopus oryzaeRhizopus oryzae
    49643-118RhizopusRhizopus oryzae

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.